CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS
Trial details
- Registry ID
- NCT03401190
- Phase
- Phase 2
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRSNCT03401190 | CALC | Phase 2 | Completed | 2019-02-14Actual |
| A Study of Auxora in Patients With Severe COVID-19 PneumoniaNCT04345614 | CALC | Phase 2 | Completed | 2021-06-28Actual |
| A Study of Auxora in Patients With Critical COVID-19 PneumoniaNCT04661540 | CALC | Phase 2 | Terminated | 2021-12-21Actual |
| A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRSNCT04681066 | CALC | Phase 2 | Completed | 2024-05-15Actual |
| A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"NCT06374797 | CALC | Phase 2 | Terminated | 2026-04-06Actual |
NCT06374797 · CalciMedica, Inc.
Estimated
Actual
150 participants (planned)
122 participants (actual)
Estimated
Actual
Jul 2026
6 Apr 2026
Active not recruiting
Terminated
NCT06374797 · CalciMedica, Inc.
Apr 2026
Jul 2026
NCT06374797 · CalciMedica, Inc.
Mar 2026
Apr 2026
Recruiting
Active not recruiting
NCT04661540 · CalciMedica, Inc.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Measure: Change From Baseline in Combined CD4, CD8, and Monocyte Cell Population in BAL Fluid, as a Percent of Total WBC Population
Measure: Change From Baseline in Combined CD4, CD8, and Monocyte Cell Population in BAL Fluid, as a Percent of Total WBC Population.
NCT04681066 · CalciMedica, Inc.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Measure: Time to Solid Food Tolerance: gMCP-Modeling Analysis for Dose-response Relationship
Measure: Median Time to Solid Food Tolerance
Measure: Median Time to Solid Food Tolerance, With gMCP Modeling Analysis for Dose-response Relationship